申请人:The Board of Regents of the University of Texas System
公开号:US20150157633A1
公开(公告)日:2015-06-11
The present invention generally relates to protein signalling. In particular, compounds that inhibit the Wnt protein signalling pathway are disclosed. Such compounds may be used in the treatment of Wnt protein signalling-related diseases and conditions such as cancer, degenerative diseases, type II diabetes and osteopetrosis.